Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.720
-0.100 (-5.49%)
At close: Jan 8, 2026, 4:00 PM EST
1.700
-0.020 (-1.16%)
Pre-market: Jan 9, 2026, 9:10 AM EST
Onconetix Market Cap
Onconetix has a market cap or net worth of $2.67 million as of January 9, 2026. Its market cap has decreased by -7.05% in one year.
Market Cap
2.67M
Enterprise Value
2.00M
1-Year Change
-7.05%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $634.08M to $2.67M, a decrease of -99.58%. That is a compound annual growth rate of -75.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 2.67M | 10.26% |
| Dec 31, 2025 | 2.43M | -53.58% |
| Dec 31, 2024 | 5.23M | 43.56% |
| Dec 29, 2023 | 3.64M | -78.61% |
| Dec 30, 2022 | 17.02M | -97.32% |
| Feb 18, 2022 | 634.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 986.88B |
| Johnson & Johnson | 500.36B |
| AbbVie | 404.66B |
| UnitedHealth Group | 308.23B |
| AstraZeneca | 293.89B |
| Merck & Co. | 273.54B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |